EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research Advances on the Stability of mRNA Vaccines

Feiran Cheng iD, Yiping Wang, Yu Bai, Zhenglun Liang, Qunying Mao, Dong Liu, Xing Wu, Miao Xu

Viruses · 02.03.2023 · 15 (3) · 668

DOI: 10.3390/v15030668 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 02.03.2023. Verfasst von Feiran Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Products Administration Key Laboratory for Quality Research and Evaluation of Biological Products, Institute of Biological Products,…. Hauptthemen laut MEDLINE: Excipients, Commerce. Die Arbeit wurde bisher 169-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Compared to other vaccines, the inherent properties of messenger RNA (mRNA) vaccines and their interaction with lipid nanoparticles make them considerably unstable throughout their life cycles, impacting their effectiveness and global accessibility. It is imperative to improve mRNA vaccine stability and investigate the factors influencing stability. Since mRNA structure, excipients, lipid nanoparticle (LNP) delivery systems, and manufacturing processes are the primary factors affecting mRNA vaccine stability, optimizing mRNA structure and screening excipients can effectively improve mRNA vaccine stability. Moreover, improving manufacturing processes could also prepare thermally stable mRNA vaccines with safety and efficacy. Here, we review the regulatory guidance associated with mRNA vaccine stability, summarize key factors affecting mRNA vaccine stability, and propose a possible research path to improve mRNA vaccine stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExcipientsCommerceLiposomesRNA, MessengermRNA VaccinesVaccines, Synthetic

Stichwörter der Autor:innen

degradationlipid nanoparticlemRNAstabilityvaccines

Substanzen

ExcipientsLiposomesRNA, MessengermRNA VaccinesVaccines, Synthetic

Autor:innen und Institutionen

  • National Medical Products Administration Key Laboratory for Quality Research and Evaluation of Biological Products, Institute of Biological Products, National Institutes for Food and Drug Control, Beijing 102600, China.
  • National Health Commission Key Laboratory of Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing 102600, China.
  • Center for Reference Materials and Standardization, National Institutes for Food and Drug Control, Beijing 102600, China.

ORCID-Profile: Feiran Cheng

Förderung

  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Cheng, F., Wang, Y., Bai, Y., Liang, Z., Mao, Q., Liu, D., Wu, X., & Xu, M. (2023). Research Advances on the Stability of mRNA Vaccines. Viruses, 15(3), 668. https://doi.org/10.3390/v15030668

Vancouver

Cheng F, Wang Y, Bai Y, Liang Z, Mao Q, Liu D, et al. Research Advances on the Stability of mRNA Vaccines. Viruses. 2023;15(3):668. doi:10.3390/v15030668

BibTeX
@article{Cheng2023,
  author = {Cheng, Feiran and Wang, Yiping and Bai, Yu and Liang, Zhenglun and Mao, Qunying and Liu, Dong and Wu, Xing and Xu, Miao},
  title = {Research Advances on the Stability of mRNA Vaccines},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {668},
  doi = {10.3390/v15030668}
}
Kostenlos starten →